A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Five-year-old Isis was told she could not have her name printed on a personalised Nutella jar as it may be "viewed as inappropriate".
A school has cancelled its upcoming winter dance due to concerns over "dirty dancing."
Ex-Dragon's Den star Doug Richard has pleaded not guilty to a string of child sex charges after appearing before the Old Bailey.